Renal transplant
Not yet recruitingAUC‑targeted tacrolimus dosing in kidney transplant recipients
AUC‑targeted tacrolimus dosing in kidney transplant recipients
- Disease:Renal transplant
- Substances:–
Norway- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
AUC‑targeted tacrolimus dosing in kidney transplant recipients
NorwayCloxacillin and drug combination for prevention of postoperative infections in patients undergoing head and neck reconstructive surgery
Denmark
The NetherlandsCisplatin with drug combination in hyperthermic intraperitoneal chemotherapy for stage II‑III adrenocortical carcinoma patients
ItalyPhase II study of fixed‑dose, accelerated ramp‑up epcoritamab plus lenalidomide in patients with relapsed/refractory large B‑cell lymphoma after CAR‑T therapy
FranceReduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial
DenmarkEffect of baclofen, gabapentin and oxazepam on brain plasticity and motor learning in subacute stroke patients
FranceDupilumab Maintenance Dose Optimization in Adults with Eosinophilic Esophagitis: A Randomized Controlled Non‑Inferiority Study
The NetherlandsSafety and Efficacy of EscharEx (concentrate of proteolytic enzymes enriched in bromelain) in Adults with Venous Leg Ulcers
CzechiaStudy of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease
FrancePhase I study of 161Tb-PSMA-1 therapy and gallium‑68 gozetotide imaging in adult patients with metastatic clear cell renal cell carcinoma
FranceEfficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.